Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,007 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

NCT00662649

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Chatswood, Australia
  • Novartis Investigative Site Fitzroy, Australia
  • Austin Health, Department of Neurology Heidelberg, Australia
  • Novartis Investigative Site North Gosford, Australia
View all 103 locations
View Trial Details
Completed

Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients

NCT00280592

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bladder Dysfunction, +17 more
Locations
  • Unité de Médecine Physique et Réadaptation - CHU Jean Minjoz Besançon, France
  • Service de Médecine Physique et Réadaptation - Hôpital Pellegrin Bordeaux, France
  • Service de Médecine Physique et Réadaptation - Hôpital Raymond Poincaré Garches, France
  • Consultations maladies infectieuses et tropicales, Hôpital Raymond Poincaré Garches, France
View Trial Details
Completed

Psychometric Validation of Cognitive Endpoints

NCT01335633

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Holy Name Hospital Multiple Sclerosis Center Teaneck, New Jersey, United States
  • Kessler Foundation West Orange, New Jersey, United States
  • University at Buffalo Buffalo, New York, United States
  • Lauren S. Caruso White Plains, New York, United States
View Trial Details
Completed

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

NCT00395317

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • GSK Investigational Site Camperdown, New South Wales, Australia
  • GSK Investigational Site Woodville, South Australia, Australia
  • GSK Investigational Site Fitzroy, Victoria, Australia
  • GSK Investigational Site Parkville, Victoria, Australia
View all 79 locations
View Trial Details

Related conditions